Skip to content
lifestyle.thriveinsider.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Avidity Biosciences, Inc.
Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
February 26, 2026
Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders
February 23, 2026
The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA® Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1
February 18, 2026
Avidity Biosciences Announces Expected Record Date for Spin-Off
February 9, 2026